CA Patent

CA2749585A1 — Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids

Assigned to Van Andel Research Institute · Expires 2010-07-22 · 16y expired

What this patent protects

A method for treating a subject having an inflammatory or auto-immune disease with a substituted isoxazolo pyridinone. Also, a method for administering a substituted isoxazolo pyridinone to a cell to retain or increase glucocorticoid re-ceptor transrepression activity with only m…

USPTO Abstract

A method for treating a subject having an inflammatory or auto-immune disease with a substituted isoxazolo pyridinone. Also, a method for administering a substituted isoxazolo pyridinone to a cell to retain or increase glucocorticoid re-ceptor transrepression activity with only minimal glucocorticoid receptor transactivation activity.

Drugs covered by this patent

Patent Metadata

Patent number
CA2749585A1
Jurisdiction
CA
Classification
—
Expires
2010-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Van Andel Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.